Greggory C Addicks
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Greggory C Addicks has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Alex Green
Interdisciplinary School of Health Sciences, University of Ottawa
2 shared publications - Andrea Rowan-Carroll
Environmental Health Science and Research Bureau, Health Canada , Ottawa
2 shared publications - Dongryeol Ryu
Department of Infrastructure Engineering University of Melbourne Parkville VIC Australia
2 shared publications - Doyoun Kim
Korea Research Institute of Chemical Technology (KRICT)
2 shared publications - Elena Katsyuba
Laboratory of Integrative Systems Physiology, Interfaculty Institute of Bioengineering
2 shared publications - Ella Atlas
Environmental Health Science and Research Bureau, Health Canada, Ottawa, Canada
2 shared publications
Latest Publications
- Open Access
- 20 November 2026
- Published by Oxford University Press (OUP) in Toxicological Sciences
Chemical and transcriptomic analysis reveal time-dependent activation of lipid metabolism and suppression of immune pathways in human primary liver spheroids exposed to aqueous film-forming foams
Aqueous film-forming foams (AFFFs) are important sources of environmental and human exposure to per- and polyfluoroalkyl substances (PFAS), yet their mechanisms of action in human-relevant liver systems remain poorly defined. High-throughput transcriptomics (HTTr) provides a scalable approach for generating mechanistic evidence relevant to chemical hazard assessment. We applied HTTr in primary human liver spheroids to evaluate 12 AFFFs recovered from military sites across Canada following exposure to seven non-cytotoxic dilutions (0.01–0.1%) for 24 h or 10 d. Chemical characterization by high-resolution mass spectrometry revealed complex and variable PFAS profiles dominated by fluorotelomer-based substances, including fluorotelomer betaines and sulfonamidobetaines, with differing contributions from other PFAS classes. Transcriptomic biomarker and pathway analyses identified a pronounced time-dependent shift in the biological responses induced by AFFF exposure. At 24 h, most AFFFs predominantly activated cellular stress responses and pathways involved in lipid metabolism. By 10 d, these profiles transitioned toward widespread inhibition of immune and inflammatory signaling, accompanied by persistent disruption of metabolic pathways, including cholesterol biosynthesis and peroxisome proliferator-activated receptor alpha (PPARα) signaling. Despite differences in chemical composition, the tested AFFFs produced broadly concordant temporal response patterns characterized by early stress-associated transcriptional responses followed by sustained alterations in metabolic and immune-related pathways. These findings demonstrate the importance of exposure duration when evaluating complex PFAS-containing mixtures and provide mechanistic support for grouping diverse AFFF formulations and applying read-across approaches in hazard characterization.
- 20 November 2026
- Published by Oxford University Press (OUP) in Toxicological Sciences
Open AccessChemical and transcriptomic analysis reveal time-dependent activation of lipid metabolism and suppression of immune pathways in human primary liver spheroids exposed to aqueous film-forming foams
Aqueous film-forming foams (AFFFs) are important sources of environmental and human exposure to per- and polyfluoroalkyl substances (PFAS), yet their mechanisms of action in human-relevant liver systems remain poorly defined. High-throughput transcriptomics (HTTr) provides a scalable approach for generating mechanistic evidence relevant to chemical hazard assessment. We applied HTTr in primary human liver spheroids to evaluate 12 AFFFs recovered from military sites across Canada following exposure to seven non-cytotoxic dilutions (0.01–0.1%) for 24 h or 10 d. Chemical characterization by high-resolution mass spectrometry revealed complex and variable PFAS profiles dominated by fluorotelomer-based substances, including fluorotelomer betaines and sulfonamidobetaines, with differing contributions from other PFAS classes. Transcriptomic biomarker and pathway analyses identified a pronounced time-dependent shift in the biological responses induced by AFFF exposure. At 24 h, most AFFFs predominantly activated cellular stress responses and pathways involved in lipid metabolism. By 10 d, these profiles transitioned toward widespread inhibition of immune and inflammatory signaling, accompanied by persistent disruption of metabolic pathways, including cholesterol biosynthesis and peroxisome proliferator-activated receptor alpha (PPARα) signaling. Despite differences in chemical composition, the tested AFFFs produced broadly concordant temporal response patterns characterized by early stress-associated transcriptional responses followed by sustained alterations in metabolic and immune-related pathways. These findings demonstrate the importance of exposure duration when evaluating complex PFAS-containing mixtures and provide mechanistic support for grouping diverse AFFF formulations and applying read-across approaches in hazard characterization.
- Open Access
- 12 June 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 207 (1) , 161-180
Identification of four mechanisms of toxicity for per- and polyfluoroalkyl substances through transcriptomic profiling in human liver spheroids exposed to 24 PFAS
Per- and polyfluoroalkyl substances (PFAS) are persistent and widespread contaminants. Epidemiological effects of PFAS include increased serum cholesterol, decreased immune response to vaccination and disease, and increased incidence of cancer; however, PFAS modes of action remain unclear. Herein, we analyzed gene expression data from human liver spheroids that were exposed to several concentrations of 24 different PFAS. Benchmark concentration (BMC) response modeling was used to identify the 250 lowest gene BMCs for each PFAS. Hierarchical clustering analysis revealed 4 functionally diverse gene sets. Each gene set was affected by a distinct group of PFAS, whereas individual PFAS were usually part of more than 1 PFAS group. The biological roles of these gene sets relate to: (1) cholesterol biogenesis and cholesterol clearance (downregulated by 7 fluorocarbon or longer PFAS), putatively through discordance of cholesterol sensing by SCAP and LXR due to membrane integration of PFAS; (2) lipolysis (upregulated by 8 carbon or shorter PFAS); (3) innate immunity (downregulated by most PFAS); and (4) adaptive immunity (downregulated by sulfonate-type PFAS). The distinctions between the 4 PFAS groups suggest that PFAS can act through at least 4 independent mechanisms. The molecular characteristics of each PFAS group may be useful for understanding the molecular interactions leading to their effect on gene expression. Inclusion of some PFAS congeners in more than one PFAS group suggests that individual PFAS can act through multiple unrelated molecular interactions. This transcriptomic analysis offers a major advancement to the understanding of the molecular mechanisms underlying the effects of PFAS exposure and provides guidance for future work that may strengthen links between PFAS exposure and their proposed effects on human health.
- 12 June 2025
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 207 (1) , 161-180
Open AccessIdentification of four mechanisms of toxicity for per- and polyfluoroalkyl substances through transcriptomic profiling in human liver spheroids exposed to 24 PFAS
Per- and polyfluoroalkyl substances (PFAS) are persistent and widespread contaminants. Epidemiological effects of PFAS include increased serum cholesterol, decreased immune response to vaccination and disease, and increased incidence of cancer; however, PFAS modes of action remain unclear. Herein, we analyzed gene expression data from human liver spheroids that were exposed to several concentrations of 24 different PFAS. Benchmark concentration (BMC) response modeling was used to identify the 250 lowest gene BMCs for each PFAS. Hierarchical clustering analysis revealed 4 functionally diverse gene sets. Each gene set was affected by a distinct group of PFAS, whereas individual PFAS were usually part of more than 1 PFAS group. The biological roles of these gene sets relate to: (1) cholesterol biogenesis and cholesterol clearance (downregulated by 7 fluorocarbon or longer PFAS), putatively through discordance of cholesterol sensing by SCAP and LXR due to membrane integration of PFAS; (2) lipolysis (upregulated by 8 carbon or shorter PFAS); (3) innate immunity (downregulated by most PFAS); and (4) adaptive immunity (downregulated by sulfonate-type PFAS). The distinctions between the 4 PFAS groups suggest that PFAS can act through at least 4 independent mechanisms. The molecular characteristics of each PFAS group may be useful for understanding the molecular interactions leading to their effect on gene expression. Inclusion of some PFAS congeners in more than one PFAS group suggests that individual PFAS can act through multiple unrelated molecular interactions. This transcriptomic analysis offers a major advancement to the understanding of the molecular mechanisms underlying the effects of PFAS exposure and provides guidance for future work that may strengthen links between PFAS exposure and their proposed effects on human health.
- Open Access
- 13 January 2022
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 221 (2)
GCN5 maintains muscle integrity by acetylating YY1 to promote dystrophin expression
Protein lysine acetylation is a post-translational modification that regulates protein structure and function. It is targeted to proteins by lysine acetyltransferases (KATs) or removed by lysine deacetylases. This work identifies a role for the KAT enzyme general control of amino acid synthesis protein 5 (GCN5; KAT2A) in regulating muscle integrity by inhibiting DNA binding of the transcription factor/repressor Yin Yang 1 (YY1). Here we report that a muscle-specific mouse knockout of GCN5 (Gcn5skm−/−) reduces the expression of key structural muscle proteins, including dystrophin, resulting in myopathy. GCN5 was found to acetylate YY1 at two residues (K392 and K393), disrupting the interaction between the YY1 zinc finger region and DNA. These findings were supported by human data, including an observed negative correlation between YY1 gene expression and muscle fiber diameter. Collectively, GCN5 positively regulates muscle integrity through maintenance of structural protein expression via acetylation-dependent inhibition of YY1. This work implicates the role of protein acetylation in the regulation of muscle health and for consideration in the design of novel therapeutic strategies to support healthy muscle during myopathy or aging.
- 13 January 2022
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 221 (2)
Open AccessGCN5 maintains muscle integrity by acetylating YY1 to promote dystrophin expression
Protein lysine acetylation is a post-translational modification that regulates protein structure and function. It is targeted to proteins by lysine acetyltransferases (KATs) or removed by lysine deacetylases. This work identifies a role for the KAT enzyme general control of amino acid synthesis protein 5 (GCN5; KAT2A) in regulating muscle integrity by inhibiting DNA binding of the transcription factor/repressor Yin Yang 1 (YY1). Here we report that a muscle-specific mouse knockout of GCN5 (Gcn5skm−/−) reduces the expression of key structural muscle proteins, including dystrophin, resulting in myopathy. GCN5 was found to acetylate YY1 at two residues (K392 and K393), disrupting the interaction between the YY1 zinc finger region and DNA. These findings were supported by human data, including an observed negative correlation between YY1 gene expression and muscle fiber diameter. Collectively, GCN5 positively regulates muscle integrity through maintenance of structural protein expression via acetylation-dependent inhibition of YY1. This work implicates the role of protein acetylation in the regulation of muscle health and for consideration in the design of novel therapeutic strategies to support healthy muscle during myopathy or aging.
- Open Access
GCN5 Maintains Muscle Integrity by Acetylating YY1 to Promote Dystrophin Expression
This work identifies a novel role for the acetyltransferase GCN5 in regulating muscle integrity through inhibition of DNA binding activity of the transcriptional repressor YY1. Here we report that in mice a muscle-specific knockout of GCN5 ( Gcn5 skm-/- ) reduces the expression of key structural muscle proteins, including dystrophin, resulting in myopathy. Supporting our observation, a meta-analysis between the differential transcriptome of Gcn5 skm-/- muscle and all available open-access data sets identified top correlations with musculoskeletal diseases in humans. GCN5 was found to acetylate YY1 at two residues (K392 and K393), which disrupts the interaction between the YY1 zinc-finger region and DNA. De/acetylation mimics for these YY1 post-translational modifications modulated muscle structural gene expression and DNA binding. Analysis of human GTEx data also found positive and negative correlations between fiber diameter and GCN5 and YY1 respectively. Collectively, our results demonstrate that GCN5 acetyltransferase activity regulates YY1 DNA binding and expression of dystrophin to modulate muscle integrity.
Open AccessGCN5 Maintains Muscle Integrity by Acetylating YY1 to Promote Dystrophin Expression
This work identifies a novel role for the acetyltransferase GCN5 in regulating muscle integrity through inhibition of DNA binding activity of the transcriptional repressor YY1. Here we report that in mice a muscle-specific knockout of GCN5 ( Gcn5 skm-/- ) reduces the expression of key structural muscle proteins, including dystrophin, resulting in myopathy. Supporting our observation, a meta-analysis between the differential transcriptome of Gcn5 skm-/- muscle and all available open-access data sets identified top correlations with musculoskeletal diseases in humans. GCN5 was found to acetylate YY1 at two residues (K392 and K393), which disrupts the interaction between the YY1 zinc-finger region and DNA. De/acetylation mimics for these YY1 post-translational modifications modulated muscle structural gene expression and DNA binding. Analysis of human GTEx data also found positive and negative correlations between fiber diameter and GCN5 and YY1 respectively. Collectively, our results demonstrate that GCN5 acetyltransferase activity regulates YY1 DNA binding and expression of dystrophin to modulate muscle integrity.
- Open Access
- 18 September 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-14
MLL1 is required for PAX7 expression and satellite cell self-renewal in mice
PAX7 is a paired-homeobox transcription factor that specifies the myogenic identity of muscle stem cells and acts as a nodal factor by stimulating proliferation while inhibiting differentiation. We previously found that PAX7 recruits the H3K4 methyltransferases MLL1/2 to epigenetically activate target genes. Here we report that in the absence of Mll1, myoblasts exhibit reduced H3K4me3 at both Pax7 and Myf5 promoters and reduced Pax7 and Myf5 expression. Mll1-deficient myoblasts fail to proliferate but retain their differentiation potential, while deletion of Mll2 had no discernable effect. Re-expression of PAX7 in committed Mll1 cKO myoblasts restored H3K4me3 enrichment at the Myf5 promoter and Myf5 expression. Deletion of Mll1 in satellite cells reduced satellite cell proliferation and self-renewal, and significantly impaired skeletal muscle regeneration. Pax7 expression was unaffected in quiescent satellite cells but was markedly downregulated following satellite cell activation. Therefore, MLL1 is required for PAX7 expression and satellite cell function in vivo. Furthermore, PAX7, but not MLL1, is required for Myf5 transcriptional activation in committed myoblasts.
- 18 September 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-14
Open AccessMLL1 is required for PAX7 expression and satellite cell self-renewal in mice
PAX7 is a paired-homeobox transcription factor that specifies the myogenic identity of muscle stem cells and acts as a nodal factor by stimulating proliferation while inhibiting differentiation. We previously found that PAX7 recruits the H3K4 methyltransferases MLL1/2 to epigenetically activate target genes. Here we report that in the absence of Mll1, myoblasts exhibit reduced H3K4me3 at both Pax7 and Myf5 promoters and reduced Pax7 and Myf5 expression. Mll1-deficient myoblasts fail to proliferate but retain their differentiation potential, while deletion of Mll2 had no discernable effect. Re-expression of PAX7 in committed Mll1 cKO myoblasts restored H3K4me3 enrichment at the Myf5 promoter and Myf5 expression. Deletion of Mll1 in satellite cells reduced satellite cell proliferation and self-renewal, and significantly impaired skeletal muscle regeneration. Pax7 expression was unaffected in quiescent satellite cells but was markedly downregulated following satellite cell activation. Therefore, MLL1 is required for PAX7 expression and satellite cell function in vivo. Furthermore, PAX7, but not MLL1, is required for Myf5 transcriptional activation in committed myoblasts.